Atea PharmaceuticalsI Book Value per Share Over Time
| AVIR Stock | USD 3.70 0.01 0.27% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Atea PharmaceuticalsI Performance and Atea PharmaceuticalsI Correlation. Atea |
Is Atea PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atea PharmaceuticalsI. If investors know Atea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atea PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.641 | Earnings Share (1.63) | Revenue Per Share 2.31 | Quarterly Revenue Growth 2.952 | Return On Assets (0.12) |
The market value of Atea PharmaceuticalsInc is measured differently than its book value, which is the value of Atea that is recorded on the company's balance sheet. Investors also form their own opinion of Atea PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Atea PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atea PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Atea PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atea PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Atea PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atea PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Book Value Per Share Analysis
Compare Atea PharmaceuticalsInc and related stocks such as Alkermes Plc, Ironwood Pharmaceuticals, and Deciphera Pharmaceuticals Book Value per Share Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALKS | 3.2788 | 7.4441 | 7.2307 | 9.6152 | 9.6152 | 8.8085 | 7.9842 | 7.8402 | 7.5512 | 6.9114 | 6.7189 | 6.913 | 6.3822 | 7.0859 | 7.44 |
| IRWD | (25.9765) | 1.0999 | 1.3538 | 0.3299 | 0.6473 | 0.6692 | 0.4603 | 0.0664 | (1.2865) | (0.5977) | 0.3929 | 3.7345 | 4.2262 | (2.2279) | (2.34) |
| DCPH | (5.5174) | (5.5174) | (5.5174) | (5.5174) | (5.5174) | (5.5174) | (6.6875) | 10.9559 | 7.9112 | 12.7474 | 9.7466 | 5.2462 | 4.5257 | 4.1255 | 3.82 |
| PCRX | 14.176 | 2.9365 | 2.1711 | 1.2457 | 4.8663 | 5.9768 | 5.8857 | 7.0211 | 7.8518 | 8.5502 | 14.5225 | 16.5019 | 17.0253 | 18.825 | 19.77 |
| COLL | 0.7471 | 0.7471 | 0.7471 | 0.7471 | (1.6384) | 6.282 | 5.5602 | 3.4389 | 2.7854 | 2.6135 | 5.4066 | 5.8084 | 5.7595 | 5.7921 | 3.1 |
| EGRX | (1.1447) | (1.1447) | 0.1943 | 3.3242 | 5.9241 | 5.9241 | 9.7354 | 11.8616 | 10.8854 | 13.0266 | 13.7975 | 13.5202 | 18.058 | 16.25 | 17.06 |
| NBIX | 4.8122 | 1.0889 | 2.3526 | 1.8026 | 2.7984 | 5.0234 | 3.6377 | 4.2294 | 5.0395 | 6.951 | 12.0967 | 14.5243 | 17.8267 | 22.8454 | 23.99 |
| DVAX | (152) | 7.9839 | 6.7359 | 9.4912 | 3.8222 | 5.6896 | 2.3165 | 3.7928 | 1.0113 | 0.1151 | 0.5825 | 1.9127 | 4.5967 | 4.8323 | 5.07 |
| AMPH | 29.1799 | 29.1799 | 29.1799 | 31.4431 | 6.7178 | 6.5726 | 7.2563 | 7.3162 | 7.1653 | 8.1173 | 8.5528 | 9.325 | 10.8887 | 13.2481 | 13.37 |
Atea PharmaceuticalsInc and related stocks such as Alkermes Plc, Ironwood Pharmaceuticals, and Deciphera Pharmaceuticals Book Value Per Share description
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.My Equities
My Current Equities and Potential Positions
| Atea PharmaceuticalsInc | AVIR |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Massachusetts; U.S.A |
| Exchange | NASDAQ Exchange |
USD 3.7
Check out Atea PharmaceuticalsI Performance and Atea PharmaceuticalsI Correlation. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Complementary Tools for Atea Stock analysis
When running Atea PharmaceuticalsI's price analysis, check to measure Atea PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea PharmaceuticalsI is operating at the current time. Most of Atea PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Atea PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atea PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Atea PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Atea PharmaceuticalsI technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.